HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Dr.
HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy’s doxycycline capsules, 40 mg, are supplied in bottle counts of 30.
Please click here to see the full prescribing information – https://www.drreddys.com/pil/doxycycline-capsules.pdf.
As employers reconsider PBM relationships, SHARx warns switching vendors may not address the root incentives behind prescription drug costs.
“AI won’t define the future of work, people who know how to leverage AI will,” said Greg Karanastasis, SVP, talent and development, CVS Health. “Our AI Academy is one of those enablers.”
The transition is expected to be completed in early 2027.
As heat, poor air quality and Cyclospora infections raise health concerns, CVS Health is expanding education, alerts and access to care.
For P&G, the acquisition introduces a premium supplement and wellness platform, capitalizing on growing consumer interest in preventive health and personalized wellness.
Developed in collaboration with PRONANUT and supported by Vitamin Angels, the landscape analysis provides one of the most comprehensive national assessments undertaken to date of the country's vitamin A supplementation and albendazole deworming program.
In the United States, net sales increased 1.4% at constant exchange rates, while comparable sales excluding gasoline rose 0.8%. Results were pressured by lower egg prices, reduced SNAP benefits, and pharmacy pricing changes related to the Inflation Reduction Act.
New plugin allows consumers to discover new products, reorder weekly lists and build carts from Safeway in ChatGPT.
